Summary & Overview
Lymphoma and Non-Acute Leukemia with Other Procedures with MCC: Inpatient Reimbursement Overview
DRG 823 applies to inpatient hospitalizations for lymphoma and non-acute leukemia when other significant procedures are performed and a Major Complication or Comorbidity is present. This Diagnosis-Related Group reflects higher resource use and influences Medicare inpatient reimbursement by assigning a higher payment weight for cases with major complications and additional procedures.
DRG 823 Overview
DRG 823 covers inpatient stays for patients with lymphoma and non-acute leukemia who undergo other significant procedures and have a Major Complication or Comorbidity. This category captures higher-resource hospitalizations where additional operative or procedural care substantially affects costs. It is important for Medicare payment because the presence of a Major Complication or Comorbidity and qualifying procedures increase reimbursement relative to less complex groups. Accurate coding of principal diagnosis, procedures, and complications determines assignment to this Diagnosis-Related Group and the associated payment weight.